Deltex Medical Group, a global leader in oesophageal Doppler monitoring, has announced the addition of a major new hospital in the USA. The group said the hospital was a university teaching hospital in its Mid-Atlantic sales territory and the flagship site within a six hospital healthcare system. It is ranked among the top ten hospitals in the US.
The hospital evaluated ODM thoroughly in 150 patients undergoing either colorectal or urology surgery in November and December 2016.
The hospital has now started implementing ODM into its standard operating procedures for both colorectal and urological surgery.
Chief executive Ewan Phillips said: 'This is a strategically important account win for Deltex in an important teaching hospital.
'Successful implementation through the hospital and wider system should help drive our overall US sales growth as well as providing an additional highly rated reference account.
'The results from the hospital's evaluation validate the value our ODM technology offers even in those hospitals that have the very best patient outcomes.
'It is noteworthy that this US hospital was able to use ODM to improve its patients' recoveries even though its starting points for lengths of stay for these types of surgery were already around half the NHS England average.'
At 8:05am: (LON:DEMG) Deltex Medical Group PLC share price was +0.13p at 1.18p